Literature DB >> 4524622

Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity.

S H Francis, R G Leslie, L Hood, H N Eisen.   

Abstract

Cyanogen bromide cleavage of the heavy (alpha) chain of protein 315 (an immunoglobulin A mouse myeloma protein with anti-dinitrophenyl activity) yielded five fragments of which one (CN2), with 156 residues, contained the chain's entire variable region. Determination of the amino-acid sequence of CN2 showed that: (1) the variable region has appreciable homology (about 33% identities) with the variable region of the light chain from the same molecule; and (2) the constant-region sequence immediately following the probable transition from variable to constant domains is the same in the protein-315 alpha as in human gamma1 and mu chains (-Val-Ser-Ser-). The sequence of the cyanogen bromide octapeptide (CN5) from the carboxy terminus of the protein-315 heavy chain closely resembles the corresponding segments of human alpha and mu chains.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4524622      PMCID: PMC388175          DOI: 10.1073/pnas.71.4.1123

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Reversible blocking of peptide amino groups by maleic anhydride.

Authors:  P J Butler; J I Harris; B S Hartley; R Leberman
Journal:  Biochem J       Date:  1967-06       Impact factor: 3.857

2.  The N- and c-terminal amino acid sequences of the heavy chain from a pathological human immunoglobulin IgG.

Authors:  E M Press; P J Piggot; R R Porter
Journal:  Biochem J       Date:  1966-05       Impact factor: 3.857

Review 3.  The antibody problem.

Authors:  G M Edelman; W E Gall
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

4.  Phylogeny of immunoglobulins.

Authors:  H M Grey
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  The amino acid sequence of bovine carboxypeptidase A. II. Tryptic and chymotryptic peptides of the cyanogen bromide fragment F-III.

Authors:  R A Bradshaw; D R Babin; M Nomoto; N G Srinivasin; L H Ericsson; K A Walsh; H Neurath
Journal:  Biochemistry       Date:  1969-09       Impact factor: 3.162

6.  Experimental approaches to homogenous antibody populations. Myeloma proteins with antihapten antibody activity.

Authors:  H N Eisen; M C Michaelides; B J Underdown; E P Schulenburg; E S Simms
Journal:  Fed Proc       Date:  1970 Jan-Feb

7.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

8.  An improved method of testing for evolutionary homology.

Authors:  W M Fitch
Journal:  J Mol Biol       Date:  1966-03       Impact factor: 5.469

9.  Phylogeny of immunoglobulin structure and function. I. Immunoglobulins of the lemon shark.

Authors:  L W Clem; P A Small
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

10.  Phylogenetic origins of antibody structure. I. Multichain structure of immunoglobulins in the smooth dogfish (Mustelus canis).

Authors:  J Marchalonis; G M Edelman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315.

Authors:  J E McCartney; L Lederman; E A Drier; N A Cabral-Denison; G M Wu; R S Batorsky; J S Huston; H Oppermann
Journal:  J Protein Chem       Date:  1991-12

2.  Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain.

Authors:  R L Jilka; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins.

Authors:  S Rudikoff; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

4.  A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.

Authors:  N Sakato; M Semma; H N Eisen; T Azuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

5.  Amino acid sequence of the first 217 residues of a mouse heavy chain (MOPC 47A) with a domain deletion.

Authors:  E A Robinson; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

6.  Crystallization of the Fv fragment of mouse myeloma protein M315.

Authors:  R Aschaffenburg; D C Phillips; D R Rose; B J Sutton; S K Dower; R A Dwek
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

7.  Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.

Authors:  S Wain-Hobson; S K Dower; P Gettins; D Givol; A C McLaughlin; I Pecht; C A Sunderland; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

8.  Two types of immunoglobulin-negative Abelson murine leukemia virus-transformed cells: implications for B-lymphocyte differentiation.

Authors:  M Hagiya; D D Davis; T Takahashi; K Okuda; W C Raschke; H Sakano
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

9.  The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site.

Authors:  D M Segal; E A Padlan; G H Cohen; S Rudikoff; M Potter; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

10.  Structural bases for public idiotypic specificities of monoclonal antibodies directed against poly(Glu60Ala30Tyr10) and poly(Glu60Ala40) random copolymers.

Authors:  J Ruf; C Tonnelle; J Rocca-Serra; D Moinier; M Pierres; S T Ju; M E Dorf; J Thèze; M Fougereau
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.